Cannell & Co. Yield10 Bioscience, Inc. Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Yield10 Bioscience, Inc. stock. As of the latest transaction made, Cannell & Co. holds 248,113 shares of YTEN stock, worth $233,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares

248,113

Previous 258,838 4.14%

Holding current value

$233,226

Previous $85,000 30.59%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$0.2 - $0.38 $2,145 - $4,075	-10,725 Reduced 4.14%	248,113 $59,000
Q4 2022 Feb 03, 2023	BUY	$1.66 - $80.64 $162,016 - $7.87 Million	97,600 Added 60.53%	258,838 $432,000
Q3 2022 Nov 02, 2022	SELL	$2.24 - $79.2 $224 - $7,920	-100 Reduced 0.06%	161,238 $482,000
Q1 2022 May 10, 2022	SELL	$3.37 - $5.67 $46,758 - $78,671	-13,875 Reduced 7.92%	161,338 $855,000
Q4 2021 Feb 09, 2022	SELL	$4.06 - $6.54 $57,814 - $93,129	-14,240 Reduced 7.52%	175,213 $862,000
Q2 2021 Aug 09, 2021	BUY	$7.35 - $13.13 $220,522 - $393,939	30,003 Added 18.82%	189,453 $1.62 Million
Q1 2021 May 07, 2021	BUY	$5.93 - $22.77 $87,912 - $337,565	14,825 Added 10.25%	159,450 $2 Million
Q4 2020 Feb 11, 2021	BUY	$5.27 - $7.97 $271,405 - $410,455	51,500 Added 55.3%	144,625 $836,000
Q3 2020 Nov 12, 2020	BUY	$4.34 - $8.25 $173,600 - $330,000	40,000 Added 75.29%	93,125 $724,000
Q1 2020 May 05, 2020	BUY	$3.77 - $10.8 $200,281 - $573,750	53,125 New	53,125 $200,000

Others Institutions Holding YTEN

# of Institutions

Shares Held

252K

Call Options Held

Put Options Held

Vigilant Capital Management, LLC

4K
Shares

$3,760
0.0% of portfolio

View Full List

About YIELD10 BIOSCIENCE, INC.

Ticker YTEN
Exchange NASDAQ
Sector Basic Materials
Industry Agricultural Inputs
Shares Outstandng 4,914,120
Market Cap $4.62M
Description
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and disc...

More about YTEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account